Enfusion, Inc.
Index- P/E- EPS (ttm)-2.50 Insider Own0.10% Shs Outstand113.05M Perf Week-9.10%
Market Cap1.22B Forward P/E38.52 EPS next Y0.24 Insider Trans-96.80% Shs Float64.19M Perf Month-29.15%
Income-282.20M PEG- EPS next Q0.03 Inst Own- Short Float3.26% Perf Quarter-45.08%
Sales111.70M P/S10.95 EPS this Y-67.90% Inst Trans0.87% Short Ratio7.53 Perf Half Y-57.56%
Book/sh0.49 P/B18.55 EPS next Y98.32% ROA- Target Price14.00 Perf Year-
Cash/sh0.48 P/C19.00 EPS next 5Y54.50% ROE- 52W Range7.80 - 23.21 Perf YTD-56.59%
Dividend- P/FCF- EPS past 5Y- ROI-4.20% 52W High-60.66% Beta-
Dividend %- Quick Ratio11.10 Sales past 5Y- Gross Margin71.50% 52W Low17.05% ATR1.00
Employees798 Current Ratio11.10 Sales Q/Q61.10% Oper. Margin4.20% RSI (14)35.67 Volatility15.02% 9.25%
OptionableYes Debt/Eq0.00 EPS Q/Q-41.00% Profit Margin-0.50% Rel Volume0.41 Prev Close9.09
ShortableYes LT Debt/Eq0.00 EarningsMay 12 AMC Payout- Avg Volume277.78K Price9.13
Recom2.00 SMA20-20.13% SMA50-26.05% SMA200-43.33% Volume20,497 Change0.44%
Nov-15-21Initiated William Blair Outperform
Nov-15-21Initiated Stifel Buy $27
Nov-15-21Initiated Piper Sandler Overweight $26
Nov-15-21Initiated Morgan Stanley Equal-Weight $24
Nov-15-21Initiated Goldman Neutral $26
Nov-15-21Initiated Credit Suisse Neutral $26
Nov-15-21Initiated BofA Securities Buy $30
May-12-22 04:10PM  
May-10-22 10:15AM  
May-02-22 04:15PM  
Apr-29-22 04:15PM  
Mar-25-22 12:59PM  
Mar-24-22 04:47PM  
Mar-23-22 07:00AM  
Mar-09-22 08:30AM  
Mar-07-22 08:00AM  
Feb-04-22 09:38AM  
Jan-25-22 10:50AM  
Jan-06-22 08:24AM  
Jan-05-22 09:40AM  
Dec-22-21 09:00AM  
Dec-17-21 10:00AM  
Dec-08-21 06:13PM  
Dec-07-21 01:00PM  
Dec-02-21 04:26PM  
Oct-28-21 12:17PM  
Oct-25-21 06:39PM  
Oct-21-21 05:45PM  
Oct-20-21 09:08PM  
Enfusion Inc. offers software-as-a-service for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Luo RoyDirectorOct 25Buy17.001,261,59421,447,098722,707Oct 27 05:48 PM
ICONIQ Strategic Partners V, L10% OwnerOct 25Buy17.00722,70712,286,019722,707Oct 27 05:39 PM
ICONIQ Strategic Partners V, L10% OwnerOct 25Buy17.00538,8879,161,079538,887Oct 27 05:39 PM
HILLHOUSE INVESTMENT MANAGEMEN10% OwnerOct 25Sale15.89647,86210,297,7664,975,183Oct 27 04:20 PM
Bernstein Bradford EDirectorOct 25Sale15.894,075,53164,780,56531,297,606Apr 21 05:30 PM